• RADIO BISEDO

    Dëgjoni tingujt e Radios tonë

    Male.rar
    Male.rar
    Male.rar
    Male.rar
    Male.rar
    Ndëgjues
    Këngët e ndëgjuara

    YouTube Bisedo.net

    YCT-529 is an experimental, non-hormonal male contraceptive developed by YourChoice Therapeutics. It acts as a selective inhibitor of the retinoic acid receptor alpha (RAR- Mechanism of Action: It functions by targeting the RAR-

    If you are asking about a specific type of male contraceptive, or if you need to know how to open a RAR archive file (the format, rather than the "Male.rar" text), please clarify! Are you researching the ?

    Based on your search request, here is the relevant review information for in the context of recent developments for a potential new product, focusing on the YCT-529 molecule, as of April 2026:

    It is designed to be a "male pill" that targets only the necessary receptor, aimed at reducing side effects found in older, less specific studies (like those using BMS-189453).

    Studies showed 100% sterility in mice after dosing, which was found to be fully reversible after drug discontinuation.

    In July 2025, Communications Medicine published results showing the candidate was well-tolerated by male volunteers in a first-in-human study. As of January 2026, it is in active clinical development.

    Top Members

    Turulav Members Online Now

    • Show all
    • new girl member
    • New Boy Member
    member-img
    Johanna

    Active 1 Day

    member-img
    Selinae

    Active 1 Day

    member-img
    Andrea Guido

    Active 1 Day

    member-img
    Rocky deo

    Active 1 Day

    member-img
    Jhon doe

    Active 5 Day

    member-img
    Angelina

    Active 1 Day

    member-img
    Andrea Guido

    Active 1 Day

    member-img
    Jene Aiko

    Active 1 Day

    member-img
    Anna haek

    Active 1 Day

    member-img
    Andrean Puido

    Active 1 Day

    Recently Active Groups

    Turulav 4 Best Active Group

    img

    Active Group A1

    Colabors atively fabcate best breed and apcations through visionary value

    • member-img
    • member-img
    • member-img
    • member-img
    • member-img
    • member-img
    • 12+
    img

    Active Group A2

    Colabors atively fabcate best breed and apcations through visionary value

    • member-img
    • member-img
    • member-img
    • member-img
    • member-img
    • member-img
    • 12+
    img

    Active Group A3

    Colabors atively fabcate best breed and apcations through visionary value

    • member-img
    • member-img
    • member-img
    • member-img
    • member-img
    • member-img
    • 12+
    img

    Active Group A4

    Colabors atively fabcate best breed and apcations through visionary value

    • member-img
    • member-img
    • member-img
    • member-img
    • member-img
    • member-img
    • 12+

    Male.rar Apr 2026

    YCT-529 is an experimental, non-hormonal male contraceptive developed by YourChoice Therapeutics. It acts as a selective inhibitor of the retinoic acid receptor alpha (RAR- Mechanism of Action: It functions by targeting the RAR-

    If you are asking about a specific type of male contraceptive, or if you need to know how to open a RAR archive file (the format, rather than the "Male.rar" text), please clarify! Are you researching the ?

    Based on your search request, here is the relevant review information for in the context of recent developments for a potential new product, focusing on the YCT-529 molecule, as of April 2026:

    It is designed to be a "male pill" that targets only the necessary receptor, aimed at reducing side effects found in older, less specific studies (like those using BMS-189453).

    Studies showed 100% sterility in mice after dosing, which was found to be fully reversible after drug discontinuation.

    In July 2025, Communications Medicine published results showing the candidate was well-tolerated by male volunteers in a first-in-human study. As of January 2026, it is in active clinical development.

    Download App Our Turulav

    Easy Connect to Everyone

    You find us, finally, and you are already in love. More than 5.000.000 around the world already shared the same experience andng ares uses our system Joining us today just got easier!

    mbl-view